The GLP-1 pills work similarly, but these contain a higher dose of medication to compensate for absorption into the digestive ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...

Pills that work similarly to currently available injectable medications represent the next wave of metabolic disorder drugs, and Viking Therapeutics is pushing its drug candidate to the forefront with ...

Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...

The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...

Wegovy is now available as a daily pill, but experts say strict dosing schedules and more intense side effects may not make it a better option than the injection.

The new oral drug costs as little as $149 a month out of pocket and is expected to broaden access as demand for GLP-1 ...

GREENVILLE, S.C.--(BUSINESS WIRE)--Crossroads Treatment Centers (Crossroads), a leading provider of substance use disorder treatment, recently introduced injectable medications as a new treatment ...

Preventable adverse drug events associated with inpatient injectable medications affect approximately 1.2 million hospitalizations annually and result in $600,000 in extra costs per hospital annually, ...

People taking weight-loss drugs are likely to regain the weight they have lost within two years of stopping the medications, ...

In this week’s Medical Minute, Dr. Lacey Anderson said the first oral GLP-1 medication for weight loss, a pill version of ...